Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about IGG: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No summary available yet.
No AI portrait yet
| Name | IGG |
| Key Genes/Proteins | FCGRT |
graph TD
IGG["IGG"]
IGG -->|"activates"| AKT["AKT"]
IGG -->|"binds"| FCGR2A["FCGR2A"]
IGG -->|"modulates"| Inflammatory_Response["Inflammatory Response"]
IGG -->|"binds_to"| AQP4["AQP4"]
IGG -->|"correlates_with"| B_Cell_Surface["B Cell Surface"]
FcRn["FcRn"] -->|"binds"| IGG
FCRN["FCRN"] -->|"binds_to"| IGG
FCGRT["FCGRT"] -->|"encodes"| IGG
ST6GAL1["ST6GAL1"] -->|"modulates"| IGG
Fcrn["Fcrn"] -->|"binds"| IGG
FUT8["FUT8"] -->|"modulates"| IGG| Target | Relation | Type | Str |
|---|---|---|---|
| Glioblastoma Stem Cell Proliferation | associated_with | process | 0.95 |
| AKT | activates | entity | 0.95 |
| alpha2,6-sialylation | involved_in | process | 0.85 |
| Inflammatory Response | modulates | process | 0.85 |
| Anti-Inflammatory Activity | associated_with | phenotype | 0.85 |
| Canonical Secretory Pathway | associated_with | process | 0.85 |
| B Cell Surface | correlates_with | process | 0.80 |
| inflammatory conditions | biomarker_for | disease | 0.80 |
| α2,6-sialylation | involved_in | process | 0.75 |
| Source | Relation | Type | Str |
|---|---|---|---|
| FCRN | binds_to | entity | 0.95 |
| FCGRT | encodes | gene | 0.95 |
| FcRn | binds | receptor | 0.95 |
| Fcrn | binds | protein | 0.95 |
| Fcrn | transports | protein | 0.95 |
| FCGRT | modulates | gene | 0.95 |
| B Cell | expressed_in | cell_type | 0.90 |
| ST6GAL1 | regulates | gene | 0.90 |
| FCGRT | protects | gene | 0.90 |
| TRIM21 | binds | gene | 0.90 |
| FcRn | protects_against | protein | 0.90 |
| Transferrin | co_expressed_with | protein | 0.75 |
| FCGRT | regulates | gene | 0.60 |
| FCGRT | protects_against | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| NAD depletion effects on monocyte/macrophage differentiation | exploratory | Inflammatory bowel disease | 0.900 | 0.00 | Primary mouse and human monocy | proposed | N/A |
| FK866 treatment in DSS-induced colitis mouse model | validation | Inflammatory bowel disease (co | 0.900 | 0.00 | DSS-induced colitis mice | proposed | N/A |
| iPSC-derived endothelial cell iron uptake with RLS CSF exposure | exploratory | restless legs syndrome | 0.900 | 0.00 | iPSC-derived human endothelial | proposed | N/A |
| FK866 in azoxymethane/DSS colitis-associated cancer model | validation | Colitis-associated cancer | 0.850 | 0.00 | AOM/DSS-treated mice | proposed | N/A |
| FK866 mechanism validation in Rag1-/- mice | validation | Inflammatory bowel disease | 0.850 | 0.00 | Rag1-/- mice with DSS-induced | proposed | N/A |
| s:** - Compare brain penetration in FcRn+/+ vs FcRn-/- mice with engin | falsification | Neuroinflammation | 0.400 | 0.50 | mouse | proposed | $200,000 |
| s:** - Compare uptake with/without magnetic particles using tight junc | falsification | Neurodegeneration | 0.400 | 0.50 | cell_line | proposed | $120,000 |
| AAV Serotype Comparison for LRRK2 Knockdown in PD Gene Therapy | validation | Parkinson's Disease | 0.400 | 0.50 | mouse | proposed | $280,000 |
| AAV Serotype Comparison for LRRK2 Knockdown in PD | validation | Parkinson's Disease | 0.400 | 0.50 | mouse | proposed | $280,000 |
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| Bispecific brain-penetrant antibodies for treatment of Alzheimer's disease. [PMID:40425446] | Sehlin D, Hultqvist G, Michno W, Aguilar | J Prev Alzheimers Dis | 2025 | 1 |
| Effect of ferroptosis on chronic cerebral hypoperfusion in vascular dementia. [PMID:37709116] | Fu P, Chen Y, Wu M, Bao B, Yin X, Chen Z | Exp Neurol | 2023 | 1 |
| On Iron Metabolism and Its Regulation. [PMID:33925597] | Vogt AS, Arsiwala T, Mohsen M, Vogel M, | Int J Mol Sci | 2021 | 1 |
| Transferrin Receptor Is a Specific Ferroptosis Marker. [PMID:32160546] | Feng H, Schorpp K, Jin J, Yozwiak CE, Ho | Cell Rep | 2020 | 1 |
| Transferrin and transferrin receptors update. [PMID:29969719] | Kawabata H | Free Radic Biol Med | 2019 | 1 |
| Time- and dose-dependent effects of bacterial infection on iron metabolism, infl [PMID:41619877] | Lu Y, Zhang Y, Niu C | Comp Biochem Physiol A Mol Int | 2026 | 0 |
| Ayanin combats against barium sulphate nanoparticles induced hepatotoxicity via [PMID:41666660] | Zhu D, Lu Y, Jamil S, Ashfaq H, Al-Emam | J Trace Elem Med Biol | 2026 | 0 |
| Role of iron and TfR1 in the application of high‑dose ascorbate against pancreat [PMID:41789665] | Piotrowsky A, Leischner C, Schmieder H, | Oncol Rep | 2026 | 0 |
| Yangxin granules exert cardioprotective effects against acute myocardial infarct [PMID:41868900] | Huo G, Zhou Y, Wu Z, Sun S, Zhu G, Cheng | American journal of translatio | 2026 | 0 |
| Conformational dynamics study of TfR1 upon transferrin binding via NMA and MD si [PMID:41921418] | Zemmouche M, Falque G, Cadet F, Gardebie | Journal of molecular graphics | 2026 | 0 |
| [Effects of acupuncture on ferroptosis and ferritinophagy in cerebral ischemia-r [PMID:41839581] | Wang YF, Dong YS | Zhen ci yan jiu = Acupuncture | 2026 | 0 |
| The therapeutic potential of Piezo1 channel-mediated ferroptosis and its inhibit [PMID:41854751] | Nan K, Zhang L, Zhao Y, Yin S, Peng Y, H | Apoptosis : an international j | 2026 | 0 |
| The Role of Artemisinin and its Derivatives in Cancer Therapy via Ferroptosis: A [PMID:41833023] | Osmanlioglu Dag SR, Tatli Cankaya II, Oz | Anti-cancer agents in medicina | 2026 | 0 |
| Raccoon eyes [PMID:35789012] | Ning Junjie | Journal of Paediatrics and Chi | 2023 | 0 |
| The Trend of Immunotherapy Combined with Nanomedicine. [PMID:34789123] | Shigao Huang; Qi Zhao | Current medicinal chemistry | 2022 | 0 |
| Test-retest reliability for performance-based outcome measures among individuals [PMID:35123456] | ["Sions J", "Donohoe M", "Beisheim-Ryan | BMC musculoskeletal disorders | 2022 | 0 |
| Interfacial Imide Polymerization of Functionalized Filled Microcapsule Templates [PMID:36234567] | ["Wei Z", "Ma X", "Wang P", "Pan J"] | Nanomaterials (Basel, Switzerl | 2022 | 0 |
| The impact of COVID-19 and non-pharmaceutical interventions on energy returns wo [PMID:36567890] | ["Saif-Alyousfi A", "Saha A"] | Sustainable cities and society | 2021 | 0 |
| Implications of relationships with family, friends, and neighbors for changes in [PMID:33245678] | ["Fuller H"] | Journal of women & aging | 2021 | 0 |
| [Longitudinal Direct Closure of Mitral Anterior Leaflet Large Perforation for In [PMID:34876543] | Morizumi S, Enomoto Y, Ikeda K, Suzuki Y | Kyobu geka. The Japanese journ | 2021 | 0 |
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning IGG in their description or question text
Score: 0.640 · neuroinflammation · 2026-04-21
**Molecular Mechanism and Rationale** The C1Q complement system component represents a critical bridge between innate i
Score: 0.622 · neurodegeneration · 2026-04-21
## Mechanistic Overview TOM/TIM Complex Disruption Triggering Mitochondrial Integrated Stress Response (mtISR) starts fr
Score: 0.610 · neurodegeneration · 2026-04-25
Loss of retrograde NGF-TrkA support could destabilize basal-forebrain cholinergic neurons early, lowering cortical acety
Score: 0.599 · neuroinflammation · 2026-04-16
## Mechanistic Overview Selective C1q-CRP vs. C1q-IgG Axis Inhibition starts from the claim that modulating C1QA/C1QB/C1
Score: 0.590 · neurodegeneration · 2026-04-25
Transient Aβ exposure activates local kinase programs, especially CDK5/p25 and possibly GSK3β, that keep tau phosphoryla
Score: 0.560 · neuroinflammation · 2026-04-21
## Mechanistic Overview MOG-IgG induces spinal cord demyelination through Fcγ receptor-dependent macrophage activation s
Score: 0.536 · molecular neurobiology · 2026-04-20
## Mechanistic Overview Cerebrospinal NFL-Triggered Liposome Dosing Maximizes lncRNA-0021 Therapeutic Window in AD start
Score: 0.535 · neurodegeneration · 2026-04-22
## Mechanistic Overview CD36 Acts as Primary Aβ Oligomer Sensor on Perivascular Macrophages, Triggering NF-κB-Dependent
Score: 0.517 · neuroinflammation · 2026-04-21
## Mechanistic Overview Metabolic Accumulation (Ammonia/Manganese) Triggers IBA1 Downregulation via NRF2 starts from the
Score: 0.460 · molecular neurobiology · 2026-04-21
## Mechanistic Overview CSF Neurofilament Light-Triggered Astrocyte-Derived Exosome Dosing Maximizes lncRNA-0021 Therape
Score: 0.453 · neuroinflammation · 2026-04-21
## Mechanistic Overview Mitochondrial Damage-Triggered SPP1 Inflammasome Coupling starts from the claim that modulating